Denny’s (NASDAQ:DENN) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This is a 1500 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $103.79 million which missed the analyst consensus estimate of $111.08 million by 6.56 percent. This is a 44.87 percent increase over sales of $71.64 million the same period last year.
Denny’s Q3 Adj. EPS $0.16, Inline, Sales $103.79M Miss $111.08M Estimate
Denny's (NASDAQ:DENN) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This is a 1500 percent increase over earnings of $0.01 per share from the same period last year. The company
Related Posts
Morgan Stanley Maintains Underweight on Uniti Group, Lowers Price Target to $8
Morgan Stanley analyst Simon Flannery maintains Uniti Group (NASDAQ:UNIT) with a Underweight and lowers the price target from $10 to $8.
Citigroup Maintains Buy on Merus, Lowers Price Target to $37
Citigroup analyst Yigal Nochomovitz maintains Merus (NASDAQ:MRUS) with a Buy and lowers the price target from $38 to $37.
Graphite Bio Presents Preclinical Data Supporting GPH101 In Sickle Cell Disease At 49th Annual Sickle Cell Disease Association Of America National Convention
Graphite Bio, Inc. (NASDAQ:GRPH), a clinical-stage, next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious diseases, announced today the presentation of